News You Can Use

According to, the verb “curate” means “to pull together, sift through, and select for presentation, as music or website content.” (The British also use “curate” as a noun to refer to “a member of the clergy employed to assist a rector or vicar”, but we digress.) News You Can Use is our attempt to curate information that would be helpful for our readers. The items range from useful information found on the FDA website and other sources to tips from our employees for R&D companies.

The Very Real Risk Of Cheaper Drugs

May 29th, 2019
Anna Edney from Bloomberg discusses the threats to consumers as focus is shifted to cheaper drug costs. It’s no secret, everyone loves a great deal. But what happens when consumers health is put in jeopardy, just because you’re trying to get cheaper drugs. Anna Edney shows her data, documents, and interviews to try and bring …

Continue Reading

Potential Threats That Could Affect Pharma Manufacturing

May 19th, 2019
Ben Hargreaves recently discussed in his article, Five Technologies That Could Disrupt Pharma Manufacturing, some technologies that panelists at Pharma Integrates reviewed that could potentially affect the pharma industry. The panelists gave their perspective of what the industry could face over the coming years. The technologies were: 3D Printing AI (Artificial Intelligence) Digitisation Continuous Manufacturing …

Continue Reading

China’s Struggle To Shake It’s Reputational Issues in 2019

May 12th, 2019
“While 2018 was a big year for Chinese R&D on the whole, the sector hit the headlines for the wrong reasons.” That is Phil Taylor’s opening statement as he discusses the difficulties of China’s reputation problem, which plagued them in 2018. In his article, Can China’s R&D Sector Shake Its Reputational Issues In 2019?, The …

Continue Reading

To Maintain Trust In Science, Lose The Peer Review

May 4th, 2019
In their commentary article, To Maintain Trust in Science, Lose the Peer Review, Benjamin Mazer, MD, MBA and John M. Mandrola, MD share their views on the problems with peer reviews and what should be our next step moving forward to decrease mistrust when disseminating information. This article was originally published on Medscape’s news and …

Continue Reading

Staying Knowledgeable About FDA Changes

February 20th, 2018
Are you developing a new parenteral formulation?  An orphan drug or a drug delivery system? Are you working on a clinical trial design? If you’re involved with the development of new drugs, you’re probably keenly aware that the U.S. Food and Drug Administration (FDA) review process is vital for you, but you may not have …

Continue Reading

Are you new to the concept of Current Good Manufacturing Practices (cGMPs)?

November 9th, 2017
IRISYS’ experienced formulation development scientists and manufacturing unit work together to optimize the formulation and scale-up for the cGMP manufacturing of clinical trial materials and commercial pharmaceutical products. The cGMP manufacturing team complies with IRISYS’ rigorous Standard Operating Procedures and FDA Guidelines. The Facts About the Current Good Manufacturing Practices section of the FDA website …

Continue Reading